Living in a disadvantaged community may decrease the length of time a person can survive with amyotrophic lateral sclerosis, ...
Qure is planning soon to start enrolling patients in a second dose group as part of a clinical trial testing AMT-162 for SOD1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback